The Department of Psychiatry offers continuing medical education (CME) through NYU Grossman School of Medicine for psychiatrists and other interested health professionals on the latest developments in mental health. Our CME offerings include the following:

• weekly Psychiatry Grand Rounds is a lecture series featuring NYU Langone thought leaders and others on topics including evidence-based clinical updates in psychiatric care, cutting-edge research in psychiatric disorders and treatment, and mental health delivery services
• monthly Behavioral Health/Psychology Grand Rounds is a lecture series on best practices in evidence-based psychotherapy and intervention, diagnostic assessment, and neuropsychology, as well as current research updates in psychology and psychiatry
• full-day continuing medical education courses

NYU Grossman School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

We also offer continuing education (CE) credits for psychologists. NYU Langone Health and NYU Grossman School of Medicine are recognized by the New York State Education Department’s State Board for Psychology as an approved provider of CE for licensed psychologists, #PSY-0085.

Full-Day Continuing Medical Education Courses

Annual Update on Attention Deficit Hyperactivity Disorder (ADHD) Through the Lifespan

Saturday, December 7, 2024
Virtual Course

Our annual Update on Attention Deficit Hyperactivity Disorder Through the Lifespan, co-sponsored with the Dept. of Child & Adolescent Psychiatry, will focus on the latest issues and important new findings in ADHD in children, adolescents, and adults.

This day-long, virtual course will feature a fantastic lineup of specialists in the field and a breakout "Ask the Experts" session where attendees can review clinical concerns with some of our panelists. Topics for the day include: ADHD diagnosis and treatment in adults, ADHD and depression, substance use disorders and cannabis use in ADHD, adult ADHD guidelines and medication shortage issues, and treating families with a history of ADHD, among others.

Psychedelic Medicine Review

Saturday, January 25, 2025
In-person at NYU & live-streamed

Our NYU Langone Psychedelic Medicine Review will provide an overview of contemporary psychedelic research with experts in the field, covering areas including basic science research, clinical trials of psychedelic-assisted psychotherapy, observational studies, and health policy considerations.

The past decade has seen an explosion of research and interest in possible clinical uses of psychedelics such as psilocybin, ketamine, and MDMA. Psychedelic-assisted therapies have shown promise in treating mood and anxiety disorders, substance use disorders, and PTSD in randomized clinical trials, yet important questions remain regarding study methodology, safety, efficacy, and the role of co-administered non-drug therapies, and we must also consider issues of affordability and health disparities.